SLC2A3 and type 2 diabetes mellitus: Clinical studies revealed that the expression of GLUT1 and GLUT3 were decreased in the different brain areas in individuals with T2DM and AD, which may be attributed to (at least in part) the brain glucose hypometabolism (49).